Ovarian cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of ovarian cancer, 2015-2017, UK

Deaths

Deaths from ovarian cancer, 2016-2018, UK.

Survival

Survive ovarian cancer for 10 or more years, 2013-2017, England and Wales

Preventable cases

Ovarian cancer cases are preventable, UK, 2015

 

 

  • There are around 7,400 new ovarian cancer cases in the UK every year, that's 20 every day (2015-2017).
  • In females in the UK, ovarian cancer is the 6th most common cancer, with around 7,300 new cases in 2017.
  • Ovarian cancer accounts for 4% of all new cancer cases in females in the UK (2017).
  • Ovarian cancer accounts for 2% of all new cancer cases in females and males combined in the UK (2017).
  • Incidence rates for ovarian cancer in the UK are highest in females aged 75 to 79 (2015-2017).
  • Each year more than a quarter (28%) of all new ovarian cancer cases in the UK are diagnosed in females aged 75 and over (2015-2017).
  • Since the early 1990s, ovarian cancer incidence rates have remained stable in females in the UK (2015-2017).
  • Over the last decade, ovarian cancer incidence rates have decreased by a twentieth (5%) in females in the UK (2015-2017).
  • Almost 6 in 10 ovarian cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • Incidence rates for ovarian cancer are projected to rise by 15% in the UK between 2014 and 2035, to 32 cases per 100,000 females by 2035.
  • Ovarian cancer incidence rates in England in females are similar in the most deprived quintile compared with the least (2013-2017).
  • Ovarian cancer is more common in White women than Asian or Black women.
  • An estimated 41,000 women who had previously been diagnosed with ovarian cancer were alive in the UK at the end of 2010.

See more in-depth ovarian cancer incidence statistics

  • There are around 4,200 ovarian cancer deaths in the UK every year, that's 11 every day (2016-2018).
  • In females in the UK, ovarian cancer is the 6th most common cause of cancer death, with around 4,200 deaths in 2018.
  • Ovarian cancer accounts for 5% of all cancer deaths in females in the UK (2018).
  • Ovarian cancer accounts for 3% of all cancer deaths in females and males combined in the UK (2018).
  • Mortality rates for ovarian cancer in the UK are highest in females aged 85 to 89 (2016-2018).
  • Each year almost half of all ovarian cancer deaths (45%) in the UK are in females aged 75 and over (2016-2018).
  • Since the early 1970s, ovarian cancer mortality rates have decreased by around a fifth (21%) in females in the UK.
  • Over the last decade, ovarian cancer mortality rates have decreased by around a seventh (15%) in females in the UK.
  • Mortality rates for ovarian cancer are projected to fall by 37% in the UK between 2014 and 2035, to 10 deaths per 100,000 females by 2035.
  • Ovarian cancer in England is not associated with deprivation.

See more in-depth ovarian cancer mortality statistics

  • More than 7 in 10 (71.7%) of women diagnosed with ovarian cancer in England survive their disease for one year or more (2013-2017).
  • More than 4 in 10 (42.6%) of women diagnosed with ovarian cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that more than 1 in 3 (35.3%) of women diagnosed with ovarian cancer in England survive their disease for ten years or more (2013-2017).
  • Ovarian cancer survival in England is highest for women diagnosed aged under 40 years old (2009-2013).
  • Almost 9 in 10 women in England diagnosed with ovarian cancer aged 15-39 survive their disease for five years or more, compared with a fifth of women diagnosed aged 80 and over (2009-2013).
  • Ovarian cancer survival is improving and has almost doubled in the last 40 years in the UK.
  • In the 1970s, less than a fifth of women diagnosed with ovarian cancer survived their disease beyond ten years, now it's more than a third.
  • When diagnosed at its earliest stage, almost all (98%) people with ovarian cancer will survive their disease for one year or more, compared with more than 1 in 2 (54%) people when the disease is diagnosed at the latest stage.
  • When diagnosed at its earliest stage, more than 9 in 10 (93%) people with ovarian cancer will survive their disease for five years or more, compared with almost 3 in 20 (13%) people when the disease is diagnosed at the latest stage.
  • Five-year relative survival for ovarian cancer in women is below the European average in England, Wales, Scotland and Northern Ireland.

See more in-depth ovarian cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 50 UK females will be diagnosed with ovarian cancer in their lifetime
  • 11% of ovarian cancer cases in the UK are preventable.

See more in-depth ovarian cancer risk statistics

  • 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
  • 64% of patients diagnosed with ovarian cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 2% of patients diagnosed with ovarian cancer have radiotherapy as part of their primary cancer treatment.
  • 54% of patients diagnosed with ovarian cancer have chemotherapy as part of their primary cancer treatment.
See more in-depth ovarian treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

 @CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.